Product image of Ziihera (Zanidatamab) supplied by GNH India

Ziihera

Active Ingredient:
Zanidatamab
Origin:
EU

Ziihera (Zanidatamab)

Ziihera (zanidatamab) is an intravenous cancer therapy designed for HER2-positive solid tumors. This targeted treatment helps manage advanced malignancies by binding to HER2 receptors. Suitable for patients seeking precision oncology options. Short-term use under clinical supervision recommended.

Manufacturer / TM Owner

Jazz Pharmaceuticals Ireland Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zanidatamab is used to treat HER2-positive solid tumors, including breast and gastric cancers. It targets cancer cells overexpressing HER2, slowing disease progression. Patients often ask, 'what is zanidatamab used for' in advanced oncology cases. This therapy is prescribed when standard treatments are ineffective or unsuitable.

Side Effects

  • Common effects include infusion-related reactions like fever or chills during administration. Some patients report fatigue or nausea shortly after treatment. These effects are typically temporary and monitored by healthcare providers. Long-term use may require regular assessments to manage potential impacts.

Precautions & Warnings

  • Zanidatamab requires administration in a clinical setting with trained professionals. Patients should disclose all medications and medical history before starting treatment. Regular monitoring of heart function and liver enzymes is advised. Avoid use if allergic to zanidatamab or its components.

Avoid Interactions

  • Zanidatamab may interact with other HER2-targeted therapies or strong CYP3A4 inhibitors. Concomitant use with live vaccines is not recommended. Alcohol and certain supplements may alter effectiveness or increase side effects. Always consult a healthcare provider before combining treatments.

Frequently Asked Questions

Zanidatamab is used to treat HER2-positive solid tumors, such as breast or gastric cancers, when other therapies are ineffective.

It is given as an intravenous infusion in a healthcare setting, typically over 1–2 hours.

Common side effects include infusion reactions like fever or chills, fatigue, and nausea.

Use with other HER2-targeted therapies or CYP3A4 inhibitors may require medical supervision.

Long-term use requires regular monitoring for potential side effects and efficacy.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zanidatamab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT